Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | GSK GSK plc American Depositary Shares (Each representing two Ordinary Shares) | ABBV AbbVie |
|---|---|---|
| Price | $50.22 -0.1% | $263.96 +0.6% |
| StockIQ Score | 51C- Moderate Risk: High | 59C Moderate Risk: High |
| Technical | 39F | 85A |
| Fundamental | — | 57C |
| Growth | — | 34F |
| Fair Value | — | 33F |
| News | 86A | 100A+ |
| Quality | — | 42D |
| Risk | 42D | 36F |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
AbbVie (ABBV) outperforms GSK in every available category. Its investor score of 52 is significantly higher than GSK’s 37, and its technical score of 58 far exceeds GSK’s 19. ABBV also has strong fundamental (56) and growth (34) scores, while GSK lacks these details. ABBV’s overall "MODERATE" rating is stronger than GSK’s "WEAK."